MONOCLONAL-ANTIBODIES THAT INHIBIT BINDING OF PROPOLYPEPTIDE OF VONWILLEBRAND-FACTOR TO COLLAGEN - LOCALIZATION OF EPITOPES

被引:17
作者
FUJISAWA, T
TAKAGI, J
SEKIYA, F
GOTO, A
MIAKE, F
SAITO, Y
机构
[1] TOKYO INST TECHNOL,FAC BIOSCI & BIOTECHNOL,DEPT BIOL SCI,MEGURO KU,TOKYO 152,JAPAN
[2] CHEMOSERO THERAPEUT RES INST,KIKUCHI,KUMAMOTO,JAPAN
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 1991年 / 196卷 / 03期
关键词
D O I
10.1111/j.1432-1033.1991.tb15864.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We reported previously that bovine propolypeptide of von Willebrand factor (pp-vWF) binds to type I collagen. To determine the collagen-binding sites of pp-vWF we generated monoclonal antibodies (mAbs) against bovine pp-vWF. One mAb, designated TC8, very strongly inhibited the binding of pp-vWF to type I collagen; three other mAbs, designated TC2, TC6 and TC7, exhibited moderate inhibition. Competition between the mAbs for binding to intact pp-vWF revealed that the epitope for TC8 was structurally independent of that for TC6 and TC7. To determine directly the location of the epitope for each mAb on the bovine pp-vWF molecule, we tested the reactivity of mAbs by immunoblotting toward peptide fragments obtained by digestion with lysylendopeptidase. TC2 and TC8 recognized a fragment of mass 21 kDa, while TC6 and TC7 recognized a distinct fragment of 18 kDa. These two fragments were purified to homogeneity and their N-terminal amino acid sequences were determined. Comparing these sequences with the sequence of human pp-vWF, the locations of these fragments in the primary structure were estimated to be Phe570-Lys682 for the 21-kDa fragment and Glu281-Lys375 for the 18-kDa fragment. These data suggest that pp-vWF contains at least two collagen-binding sites which lie within or close to the regions between Phe570-Lys682 and Glu281-Lys375.
引用
收藏
页码:673 / 677
页数:5
相关论文
共 26 条
  • [1] NUCLEOTIDE-SEQUENCE OF PRE-PRO-VONWILLEBRAND FACTOR CDNA
    BONTHRON, D
    ORR, EC
    MITSOCK, LM
    GINSBURG, D
    HANDIN, RI
    ORKIN, SH
    [J]. NUCLEIC ACIDS RESEARCH, 1986, 14 (17) : 7125 - 7127
  • [2] STRUCTURE OF PRE-PRO-VON WILLEBRAND FACTOR AND ITS EXPRESSION IN HETEROLOGOUS CELLS
    BONTHRON, DT
    HANDIN, RI
    KAUFMAN, RJ
    WASLEY, LC
    ORR, EC
    MITSOCK, LM
    EWENSTEIN, B
    LOSCALZO, J
    GINSBURG, D
    ORKIN, SH
    [J]. NATURE, 1986, 324 (6094) : 270 - 273
  • [3] EVIDENCE THAT THE PRIMARY BINDING-SITE OF VON-WILLEBRAND FACTOR THAT MEDIATES PLATELET-ADHESION ON SUBENDOTHELIUM IS NOT COLLAGEN
    DEGROOT, PG
    OTTENHOFROVERS, M
    VANMOURIK, JA
    SIXMA, JJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1988, 82 (01) : 65 - 73
  • [4] PROPOLYPEPTIDE OF VONWILLEBRAND-FACTOR CIRCULATES IN BLOOD AND IS IDENTICAL TO VONWILLEBRAND ANTIGEN-II
    FAY, PJ
    KAWAI, Y
    WAGNER, DD
    GINSBURG, D
    BONTHRON, D
    OHLSSONWILHELM, BM
    CHAVIN, SI
    ABRAHAM, GN
    HANDIN, RI
    ORKIN, SH
    MONTGOMERY, RR
    MARDER, VJ
    [J]. SCIENCE, 1986, 232 (4753) : 995 - 998
  • [5] FRESSINAUD E, 1987, BLOOD, V70, P1214
  • [6] CLEAVAGE OF STRUCTURAL PROTEINS DURING ASSEMBLY OF HEAD OF BACTERIOPHAGE-T4
    LAEMMLI, UK
    [J]. NATURE, 1970, 227 (5259) : 680 - +
  • [7] BIOSYNTHESIS OF THE SUBUNITS OF FACTOR-VIIIR BY BOVINE AORTIC ENDOTHELIAL-CELLS
    LYNCH, DC
    WILLIAMS, R
    ZIMMERMAN, TS
    KIRBY, EP
    LIVINGSTON, DM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (09): : 2738 - 2742
  • [8] STUDIES ON A NEW PROTEOLYTIC-ENZYME FROM ACHROMOBACTER-LYTICUS M497-1 .1. PURIFICATION AND SOME ENZYMATIC-PROPERTIES
    MASAKI, T
    TANABE, M
    NAKAMURA, K
    SOEJIMA, M
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1981, 660 (01) : 44 - 50
  • [9] ENDOTHELIAL CELL SYNTHESIS OF VONWILLEBRAND ANTIGEN-II, VONWILLEBRAND-FACTOR, AND VONWILLEBRAND-FACTOR VONWILLEBRAND ANTIGEN-II COMPLEX
    MCCARROLL, DR
    LEVIN, EG
    MONTGOMERY, RR
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1985, 75 (04) : 1089 - 1095
  • [10] MOHRI H, 1989, J BIOL CHEM, V264, P17361